METHOD OF CULTURING SINGLE B-CELL Russian patent published in 2019 - IPC G01N33/50 G01N33/53 

Abstract RU 2709531 C2

FIELD: biotechnology.

SUBSTANCE: group of inventions relates to biotechnology, specifically to a method of producing B-cells secreting antigen-specific antibodies. Following steps are taken to obtain B-cells: obtaining B cells from rabbit blood; labelling of IgG + -B-cells and/or CD138 + -B-cells; incubation of B-cells at temperature of 37 °C for one hour in a medium for co-cultivation before placing labelled B-cells in form of single cells with subsequent combined cultivation with feeder cells in a medium for co-cultivation; selection of B-cell, proliferating at this stage; obtaining B-cells. Method may also include a step for centrifugation of separately placed B-cells before combined cultivation. Feeder cells are murine EL-4 B5 cells, and the feeder mixture contains interleukin-1-beta, tumour necrosis factor alpha, Staphylococcus aureus cells Cowan, BAFF, interleukin-2, and/or interleukin-10, and/or interleukin-6, and/or interleukin-4. To obtain antibodies, a mature B-cell population derived from rabbit blood is taken; marking of IgG + -B-cells and/or CD138 + -B-cells with at least one fluorescent label; B cells are incubated at temperature of 37 °C for one hour in a medium for co-cultivation before placing single cells from the population of labelled B-cells into separate containers; cultivating separately placed B-cells in the presence of feeder cells and a feeder mixture; specificity of antibody binding and amino acid sequence of variable domains of light and heavy chains of specifically binding antibodies by PCR with reverse transcription; introducing a nucleic acid encoding the variable domains of the light and heavy chains of the monoclonal antibody for antibody expression; introducing nucleic acid into a cell; culturing the cell and isolating the antibody from a cell or cell supernatant.

EFFECT: group of inventions enables fast characterization of binding of monoclonal antibodies prepared from individual B-cell clones obtained from rabbit blood.

7 cl, 13 tbl, 22 ex

Similar patents RU2709531C2

Title Year Author Number
SINGLE B-CELL CULTIVATION METHOD 2011
  • Ehndl' Jozef
  • Shumakher Natali
  • Offner Zonja
  • Plattser Jozef
  • Zive Bazile
  • Torej Irmgard
RU2575569C2
MAMMALIAN CELLS EXPRESSING CD40L LIGAND AND THEIR APPLICATION 2012
  • Endl Jozef
  • Fisher Ens
  • Kern Peter
  • Offner Zonya
  • Plattser Jozef
  • Zeeber Stefan
RU2627597C2
MEANS AND METHODS FOR OBTAINING HIGH-AFFINITY ANTIBODIES 2011
  • Bomon, Tim
  • Kvakkenbos, Mark Erun
  • Spits, Khergen
  • Bakker, Adrianus, Kvirinus
  • Vagner, Kun
RU2585153C2
DISPLAY SYSTEM BASED ON FULL LENGTH ANTIBODY FOR EUKARYOTIC CELLS, AND ITS APPLICATION 2012
  • Khyulsmann Peter Mikhel
  • Netgen Khendrik
RU2625033C2
METHODS FOR IDENTIFICATION OF IMMUNE BINDERS OF CELL SURFACE ANTIGENS 2016
  • Khulman-Kote, Valeri
  • Urekh, Devid
RU2635186C2
METHOD FOR PRODUCING HYBRID/CHIMERIC CELLS AND USING THEM 2010
  • Kaseko Galina
  • Makhavorasilpa Tokhsak L.
RU2536978C2
FUSED PARTNER CELL 2007
  • Jamamoto Naomasa
  • Kaneda Mizukho
RU2431667C9
QUICK METHOD OF CLONING AND EXPRESSION OF RELATED ANTIBODY VARIABLE REGION GENE SEGMENTS 2012
RU2612910C2
METHOD OF IDENTIFICATION OF IMMUNE BINDERS FOR SURFACE ANTIGENS OF CELLS 2010
  • Khulman-Kote Valeri
  • Urekh Devid
RU2577965C2
METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS 2014
  • Khinrichs Kristian S.
  • Rozenberg Stiven A.
RU2713333C2

RU 2 709 531 C2

Authors

Endl Jozef

Shukhmakher Natali

Offner Zonya

Plattser Jozef

Zive Bazile

Torej Irmgard

Dates

2019-12-18Published

2011-05-26Filed